Arctic Bioscience AS Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	-	79.6	144.15	227.36
Cash & Short-Term Investments	-	-	79.6	144.15	227.36
Cash Growth	-	-	-44.78%	-36.60%	1704.45%
Accounts Receivable	10.21	14.57	9.57	13.48	7.7
Other Receivables	8.2	11.05	11.19	5.24	3.34
Total Trade Receivables	18.4	25.62	20.76	18.71	11.05
Inventory	29.62	28.99	32.79	35.46	28.53
Total Current Assets	49.31	57.89	133.15	198.33	266.93
Net Property, Plant & Equipment	22.81	24.47	26.44	22.33	15.99
Other Intangible Assets	211.19	195.46	138.13	107.04	58.55
Goodwill	1.34	1.93	2.53	0	-
Total Assets	284.65	279.74	300.25	327.7	341.47
Accounts Payable	26.03	18.98	18.38	18.25	8.36
Accrued Expenses	1.88	2.08	2.25	1.74	2.42
Current Portion of Long-Term Debt	34.12	20.24	0	-	0
Other Current Liabilities	20.94	26.25	19.02	20.43	10.13
Total Current Liabilities	82.97	67.54	39.65	40.42	20.92
Long-Term Debt	27.35	0	2.05	0	-
Other Long-Term Liabilities	0.84	1.47	-	-	-
Total Long-Term Liabilities	28.2	1.47	2.05	0	-
Total Liabilities	111.17	69.01	41.69	40.42	20.92
Common Stock	2.7	2.54	2.54	2.44	2.43
Additional Paid-in Capital	170.79	208.19	256.02	284.84	318.12
Shareholders' Equity	173.49	210.73	258.56	287.28	320.55
Total Liabilities & Equity	284.65	279.74	300.25	327.7	341.47
Total Debt	61.48	20.24	2.05	0	0
Net Cash (Debt)	-61.48	-20.24	77.55	144.15	227.36
Net Cash Growth	-	-	-46.20%	-36.60%	5385.57%
Net Cash Per Share	-1.98	-0.80	3.05	5.89	9.34
Book Value	173.49	210.73	258.56	287.28	320.55
Book Value Per Share	5.58	8.31	10.17	11.74	13.17
Tangible Book Value	-39.04	13.34	117.9	180.24	262.01
Tangible Book Value Per Share	-1.26	0.53	4.64	7.36	10.77